1. Home
  2. NWTG vs GNPX Comparison

NWTG vs GNPX Comparison

Compare NWTG & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newton Golf Company Inc.

NWTG

Newton Golf Company Inc.

N/A

Current Price

$1.60

Market Cap

7.3M

ML Signal

N/A

Logo Genprex Inc.

GNPX

Genprex Inc.

N/A

Current Price

$1.93

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NWTG
GNPX
Founded
2018
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
6.4M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
NWTG
GNPX
Price
$1.60
$1.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.9K
824.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
76.33
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$128.27
N/A
Revenue Next Year
$70.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$0.14
52 Week High
$3.50
$12.97

Technical Indicators

Market Signals
Indicator
NWTG
GNPX
Relative Strength Index (RSI) 54.31 43.68
Support Level $1.51 $1.90
Resistance Level $1.79 $2.51
Average True Range (ATR) 0.10 0.20
MACD 0.00 0.01
Stochastic Oscillator 67.27 12.54

Price Performance

Historical Comparison
NWTG
GNPX

About NWTG Newton Golf Company Inc.

Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: